Terminology
DIN 1a |
intraduct hyperplasia, IDH |
||
DIN 1b |
flat epithelial atypia |
||
DIN 1c |
atypical intraduct hyperplasia and low grade DCIS |
||
DIN 2 |
grade 2 DCIS |
||
DIN 3 |
grade 3 DCIS |
High molecular weight cytokeratins may be useful in distinguishing usual ductal hyperplasia from in situ carcinoma
|
||||
Usual ductal hyperplasia |
+++3 |
+++3 |
||
Atypical ductal hyperplasia |
-/+3 |
-3 |
||
Ductal carcinoma in situ |
-/+3 |
-3 |
||
Lobular carcinoma in situ |
+++3 |
-3 |
||
Atypical ductal hyperplasia stains for pure epithelial cytokeratins (CK7, CK18, CK19), while usual interstitial hyperplasia shows a mix of luminal and basal cytokeratins (CK5/6, CK7, CK14, CK18, CK19)4. Atypical hyperplasia and DCIS express high levels of oestrogen receptors in nearly all cells, while usual epithelial hyperplasia shows heterogeneous expression4.
Differentiating ductal (DCIS, DIN) from lobular (LCIS, LIN) intra-epithelial mammary hyperplasia can usually be performed on H/E microscopy. However, some cases show an intermediate morphology, and may be designated as mammary intra-epithelial neoplasia (MIN). In particular, the solid variant of low grade DCIS (DIN 1c) may closely resemble CLIS. The combined e-cadherin and HMW cytokeratin immunoprofile may be useful in these cases. However, some cases also show a hybrid immunoprofile which differs from both classical lobular and classical ductal intra-epithelial neoplasia: further research is needed into such cases.
|
e-cadherin- / 34ßE12+ |
e-cadherin+ / 34ßE12- |
e-cadherin+ / 34ßE12+ |
e-cadherin- / 34ßE12- |
|
classical lobular (LIN, all grades) |
0/401 |
0/401 |
0/401 |
||
classical ductal (DIN 1c to 3) |
0/201 |
20/201 |
0/201 |
0/201 |
|
hybrid MIN |
6/501 |
||||
Optimum staining for 34ßE12 required a heat-retrieval method. Note that other studies have shown that low grade DIN 1a (intraduct hyperplasia, IDH) is immunoreactive for 34ßE122.
References
This page last revised 17.9.2004.
©SMUHT/PW Bishop